Results 171 to 180 of about 2,192,791 (336)
Open Archives meet Open Peer Review?
I sketch the development of the Los Alamos e-print archive (arXiv). I then highlight some concepts of the Open Archives Initiative (OAI) protocol and briefly comment on the relation of arXiv to peer review.
Buckingham Shum, Simon, Li, Gary
openaire +1 more source
'Reviews in History' and peer review in the digital age [PDF]
This paper discusses the development of the IHR's open access reviews journal, Reviews in History, and goes on to consider some of the ways in which peer review, both pre- and post-publication, might evolve in the coming months and years. It was given
Winters, Jane
core
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris +10 more
wiley +1 more source
Transparency in Open Science: An Actionable Principle?
This review discusses the concept of transparency as a cornerstone for the open science (OS) paradigm and the open access movement. To this regard, the contribution presents a review of official positions of supra-national bodies regarding OS and ...
Cruz Romero Roberto
doaj +1 more source
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source
Acknowledgement to reviewers [PDF]
The Journal of Interdisciplinary Sciences (JIS) wishes to thank all the reviewers for their intellectual contributions by timely reviewing manuscripts, and supporting the journal’s vision of “Enriching Beautiful Minds towards Intelligent Minds”.
Editor-in-Chief
doaj
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source

